Home>Mutual Funds>Aditya Birla Sun Life Mutual Fund>Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
1M
6M
1Y
All
| NAV: 26 Nov 2021 | ₹20.02 |
| Min. SIP amount | ₹500 |
| Rating | NA |
| Fund size | ₹567.26Cr |
Returns and rankings
Category: Equity Sectoral / Thematic
Absolute returns
| 3M | 6M | 1Y | All | |
|---|---|---|---|---|
| Fund returns | -0.1% | 5.5% | 27.1% | 100.2% |
| Category average | NA | NA | 58.4% | NA |
| Rank with in category | 7 | 5 | 5 | NA |
Understand terms
Holdings (25)
| Name | Sector | Instrument | Assets |
|---|---|---|---|
Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 12.7% |
Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 10.0% |
Divi's Laboratories Ltd. | Healthcare | Equity | 9.8% |
Cipla Ltd. | Healthcare | Equity | 9.5% |
Alkem Laboratories Ltd. | Healthcare | Equity | 5.3% |
Gland Pharma Ltd. | Healthcare | Equity | 4.6% |
Torrent Pharmaceuticals Ltd. | Healthcare | Equity | 4.6% |
Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 4.2% |
Aurobindo Pharma Ltd. | Healthcare | Equity | 3.8% |
Ipca Laboratories Ltd. | Healthcare | Equity | 3.1% |
See All
Expense ratio, exit load and tax
Expense ratio: 1.12%
Inclusive of GST
Exit load
Exit load of 1% if redeemed within 30 days.
Stamp duty
0.005% (from July 1st, 2020)
Tax implication
NA
Understand terms
Check past data
Minimum investment amounts
| Min. for 1st investment | ₹1,000 |
| Min. for 2nd investment onwards | ₹1,000 |
| Min. for SIP | ₹500 |
Fund management
Dhaval Shah
Jun 2019 - Present
View details
Fund house & investment objective
Fund house contact details
Compare funds
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
VS
Add mutual fund to compare
